6-Bromo-2,3-dichloroquinoxaline is a heterocyclic compound characterized by its quinoxaline backbone, which consists of a fused benzene and pyrazine ring. This compound features bromine and chlorine substituents at specific positions, which can significantly influence its chemical reactivity and biological activity. The presence of halogens often enhances the lipophilicity and can affect the compound's interaction with biological targets. 6-Bromo-2,3-dichloroquinoxaline is typically used in research settings, particularly in medicinal chemistry, due to its potential as a pharmacophore in drug development. Its structural characteristics may contribute to its role as an inhibitor or modulator in various biochemical pathways. Additionally, the compound's stability, solubility, and reactivity can vary based on the conditions under which it is handled, making it essential to consider these factors in experimental applications. Safety precautions should be observed when working with this compound, as halogenated compounds can pose health risks.

6-bromo-2,3-dichloroquinoxaline

108229-82-9: 6-Bromo-2,3-dichloroquinoxaline is a heterocyclic compound characterized by its quinoxaline backbone, which consists of a fused benzene and pyrazine ring. This compound features bromine and chlorine substituents at specific positions, which can significantly influence its chemical reactivity and biological activity. The presence of halogens often enhances the lipophilicity and can affect the compound's interaction with biological targets. 6-Bromo-2,3-dichloroquinoxaline is typically used in research settings, particularly in medicinal chemistry, due to its potential as a pharmacophore in drug development. Its structural characteristics may contribute to its role as an inhibitor or modulator in various biochemical pathways. Additionally, the compound's stability, solubility, and reactivity can vary based on the conditions under which it is handled, making it essential to consider these factors in experimental applications. Safety precautions should be observed when working with this compound, as halogenated compounds can pose health risks.

CAS 108229-82-9

6-bromo-2,3-dichloroquinoxaline

6-Bromo-2,3-dichloroquinoxaline

Ref: IN-DA007V5G

6-Bromo-2,3-dichloroquinoxaline

Ref: 54-OR74482

6-Bromo-2,3-dichloroquinoxaline

Ref: 10-F227166